J.P. Morgan and BofA Merrill Lynch, William Blair and Stifel assisted
By Devika Patel
Knoxville, Tenn., June 11 – EndoChoice said the underwriters for its initial public offering of stock opted to exercise the deal’s $14.29 million greenshoe in full, lifting total proceeds of the offering to $109.54 million. The deal priced for $95.25 million with the greenshoe on June 4.
The company sold 7,302,500 common shares at $15.00 per share. Of the shares, 952,500 were part of the fully exercised greenshoe.
J.P. Morgan and BofA Merrill Lynch were the bookrunners.
Based in Atlanta, the medical technology company makes and sells technologies for screening, diagnosing and treating gastrointestinal conditions. The company intends to list its common stock on the NYSE exchange under the symbol “GI.”
| Issuer: | EndoChoice
|
| Issue: | Common stock
|
| Amount: | $109,537,500, including $14,287,500 greenshoe of 952,500 shares
|
| Shares: | 7,302,500
|
| Price: | $15.00
|
| Warrants: | No
|
| Bookrunners: | J.P. Morgan and BofA Merrill Lynch
|
| Co-managers: | William Blair and Stifel
|
| Pricing date: | June 4
|
| Settlement date: | June 11
|
| Stock exchange: | NYSE: GI
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
